Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Urol
Asıl Yazarlar: Pilskog, Martin, Beisland, Christian, Akslen, Lars A., Bostad, Leif, Haug, Åse, Heinrich, Daniel, Hjelle, Karin M., Straume, Oddbjørn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580299/
https://ncbi.nlm.nih.gov/pubmed/28859644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0267-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller